Schroder Investment Management Group
ISEE

Schroder Investment Management Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Schroder Investment Management Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-264,937
Closed -$10.4M – 1265
2023
Q2 		$10.4M Sell
264,937
-62,740
-19% -$2.21M 0.02% 627
2023
Q1 		$7.97M Buy
327,677
+98,392
+43% +$2.15M 0.01% 684
2022
Q4 		$4.91M Buy
+229,285
New +$4.89M 0.01% 782

Schroder Investment Management Group's ISEE Position: Q3 2023 in Review

Schroder Investment Management Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 264,937 shares — an estimated $10.4M sold.

Schroder Investment Management Group first reported a position in ISEE in Q4 2022 and held it in 3 quarters. The position peaked at $10.4M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Schroder Investment Management Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 264,937 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $10.4M.
  • Schroder Investment Management Group first reported a position in IVERIC bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Schroder Investment Management Group's IVERIC bio, Inc. Common Stock position peaked at $10.4M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Schroder Investment Management Group's 13F filing for Q3 2023, filed 14 Nov 2023.